Literature DB >> 3699409

Pyloric dysfunction in diabetics with recurrent nausea and vomiting.

F Mearin, M Camilleri, J R Malagelada.   

Abstract

Diabetes mellitus has been associated with a variety of gastrointestinal motor disturbances. Pyloric activity, however, has not been specifically investigated. We have quantified the pyloric manometric profile in 24 diabetics with recurrent nausea or vomiting, or both, without evidence of mechanical obstruction. Twelve healthy volunteers served as controls. A multilumen pneumohydraulic perfusion assembly with five side openings, each 1 cm apart, was positioned fluoroscopically across the antroduodenal junction and used to monitor pressure activity for 5 h (3 h fasting and 2 h fed). Three patterns of pyloric activity were defined and quantified: (a) baseline elevation of greater than or equal to 3 mmHg for greater than or equal to 1 min (tonic pattern); (b) antral-type phasic pressure activity mixed with duodenal phasic activity (phasic pattern); and (c) phasic pattern superimposed on tonic activity (combined tonic-phasic pattern). The duration of the total pyloric activity before and after the meal was greater in diabetics than in controls (p less than 0.005). Furthermore, episodes of unusually prolonged (greater than or equal to 3 min) and intense (greater than or equal to 10 mmHg) tonic contraction, "pylorospasm," were observed in 14 of 24 diabetics but in only 1 control (p = 0.025). In diabetics, episodes of pylorospasm had a peak amplitude of tonic activity of 13 +/- 1 mmHg and a duration of 7 +/- 0.7 min (mean +/- SE). We conclude that pyloric dysmotility forms part of the widespread disruption of gut motility that affects some patients with diabetes.

Entities:  

Mesh:

Year:  1986        PMID: 3699409     DOI: 10.1016/0016-5085(86)90262-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  94 in total

Review 1.  The use of botulinum toxin for the treatment of gastrointestinal motility disorders.

Authors:  Frank Friedenberg; Satya Gollamudi; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

2.  Hyperglycaemia stimulates pyloric motility in normal subjects.

Authors:  R Fraser; M Horowitz; J Dent
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

Review 3.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

4.  Comparison between gastric emptying of digestible and indigestible solids in diabetic patients.

Authors:  A Brogna; F Catalano; A Mangiameli; S Monello; R Ferrara; A M Bucceri; A Marletta
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 5.  Endoscopy in the diagnosis and management of motility disorders.

Authors:  Yael Kopelman; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

6.  Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus.

Authors:  M Samsom; L M Akkermans; R J Jebbink; H van Isselt; G P vanBerge-Henegouwen; A J Smout
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 7.  Gastrointestinal disturbances in diabetes.

Authors:  Manju Chandran; Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

8.  Electroacupuncture restores impaired gastric accommodation in vagotomized dogs.

Authors:  Hui Ouyang; Jinhong Xing; Jdz Chen
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Hypoglycemic Effects of Intestinal Electrical Stimulation by Enhancing Nutrient-Stimulated Secretion of GLP-1 in Rats.

Authors:  Feng Ye; Yi Liu; Shiying Li; Jiande D Z Chen
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

10.  Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia.

Authors:  V Stanghellini; C Ghidini; M R Maccarini; G F Paparo; R Corinaldesi; L Barbara
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.